Möchten Sie immer auf dem neuesten Stand bleiben?

BOSTON, MA--(Marketwired - Apr 6, 2016) - Crack open a map and you'll see what we see: lots of great travel destinations are just a stone's throw away from other intriguing spots, offering an ideal...

TORONTO, ON--(Marketwired - Apr 6, 2016) - With a loonie that's still in the doldrums, it pays to stretch your travel dollars as far as possible. To help expand your holiday possibilities, the...

Raleigh, April 06, 2016 (GLOBE NEWSWIRE) -- RegEd, the leading provider of compliance and risk management technology to broker-dealers and other financial services firms, today announced...

EWING, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today disclosed that the “Pen 1” development project with Teva Pharmaceutical Industries, Ltd. (Teva) relates to...

The US Patent and Trademark office has announced to Vigmed that it intends to grant the Company an additional patent for their needle protecting solution found in the product lines CLiP® and...

New Medtronic Treatment Targets Underlying Bladder and Brain Miscommunication and Could Bring Desperately Needed Relief to Tens of Millions Struggling with OAB DUBLIN - March 30, 2016 - Medtronic...

SAN FRANCISCO, CA--(Marketwired - Mar 30, 2016) - 10fold, a full-service B2B technology public relations agency, was honored as a runner-up in the 2016 PRWeek Awards, Technology Campaign of the...

- Completed Patient Enrollment in Pivotal Phase 3 ADAPT Clinical Trial of AGS-003 in July 2015 –  - Independent Data Monitoring Committee (IDMC) Recommended Continuation of Pivotal Phase 3...

MENLO PARK, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc.  (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...

EWING, N.J., March 29, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced the approval by the U.S. Food and Drug Administration (FDA) of three new dosage strengths of...